NEWS

Welcome to UBIFRANCE, the french Trade Commission Portal

News in your activities

Search

23 French exhibitors at the Photonics West tradeshow in San Francisco

Nathalie Marchal - 13-janv.-2017 22:37:29

  23 French exhibitors at the Photonics West tradeshow in San Francisco   From January 31 st to February 2 nd , 2017 Organised by Business France in partnership with the CNOP (National Committee for Optics and Photonics), the French Pavilion at the Photonics West tradeshow in February 2016 will gather 24 exhibitors. Among them, there will be French competitiveness cluster who are CNOP members: Alpha – Route des Lasers & des Hyperfréquences, as well as the Bretagne International agency, which groups several businesses in its area. Located in the Moscone Center South Hall, in booths 1723 and 1823, the French Pavilion will extend over a 1600 sq feet surface area. The French optic and photonics represents about a thousand companies and 50,000 direct jobs, a turnover of €10,45b, 300 laboratories and 13,000 researchers (Source: AFOP). As for business sectors, while it is still positioned on the defence market, it is making increasing inroads into sectors such as security, aeronautics, automotive, space, health, telecommunications, instrumentation and industrial processes.   90% of French industrialists export their production. Those exports represent about 50% of the business channel’s overall turnover. Research conducted in France covers a wide range of fields: fundamental physics, astrophysics, micro and nanotechnology, light/matter interaction and materials, thereby taking part in the progress of other disciplines. All French research agencies are presently involved in ambitious projects: the large telescopes of the future, satellites to observe the workings of the universe, extreme lasers, and they are associated with the instrumentation needed in such undertakings as the ITER, VIRGO and LHC projects. Beyond the exceptional advances they are expected to trigge r, those projects are also significantly stimulating industrial activity around optics photonics. Furthermore, they are playing a role in creating a strong synergy between research laboratories and industry, a synergy which is essential to a dynamic business environment and which has brought about a strong showing of French projects within the framework of European calls for tender. Innovative in the field of optics and photonics, French companies exhibiting in San Francisco will be unveiling their latest products at the tradeshow. The catalogue of exhibitors is available on request. Contact: Business France Nathalie Marchal, Electronic & Digital Project Coordinator Nathalie.marchal@businessfrance.fr

Defymed Enters Partnership with Semma Therapeutics

PRESS RELEASE - 13-déc.-2016 18:26:41

Defymed enters partnership with Semma Therapeutics Strasbourg, 12 December 2016 - Defymed, a Strasbourg biotech company specialising in the development of bio-artificial organs, announces a strategic collaboration with Semma Therapeutics, an American biotechnology company specialising in the development of cell therapies for the treatment of diabetes, with the goal of developing of an innovative solution for treating type-1 diabetes. The collaboration is aimed at pre-clinical validation of the MAILPAN® bio-artificial pancreas, a device developed by Defymed, in combination with stem-cell derived differentiated insulin-secreting cells developed by Semma Therapeutics. The combination will be evaluated for effectiveness and safety, at first in vitro and then in an animal model. MAILPAN® is a medical device in the form of a pouch made of bio-compatible polymer comprising semi-permeable membranes that allow glucose, nutriments and oxygen to pass through and hence to reach the pancreatic cells contained in the device, delivering the insulin required to regulate the patient’s blood-sugar level. The membranes are impermeable to the immune system and its antibodies, thereby protecting the patient from rejection of the implanted cells. If successful, the collaboration could be an important step in the fight against the global epidemic of diabetes. Diabetes affects more than 420 million people globally, accounting for around $700B in healthcase spending. Type 1 diabetes alone accounts for $14.9 billion in healthcare costs in the U.S., with 1.25M patients on insulin therapy for the disease. In France, it is estimated that 300 000 people have type-1 diabetes, and 2 000 new cases are diagnosed each year. This therapy would potentially offer the patient an unlimited source of insulin-secreting cells, unlike pancreatic islets which are limited by their availibility. Additionally, the device should obviate the need for immuno-suppression treatment, as its membranes as expected to protect the encapsulated cells from any risk of rejection. The patient would no longer have to think about multiple insulin injections each day, as the MAILPAN® combined with Semma’s cells should deliver the right amount of insulin. Defymed’s autonomous and long-lasting medical device thereby is hoped to substantially reduce the complications connected with diabetes. “Semma Therapeutics’ expertise could represent a major new source for cells usable in our medical device,” said Dr Séverine Sigrist, Founding President of Defymed. “It is vital in Defymed’s strategy to validate our medical device with what are currently the most promising cells. We believe the approach developed by Semma is the most advanced worldwide. Everything points to our collaboration being a great success. So I welcome this partnership, which looks very promising indeed!” “Defymed offers one of the most promising options available today in terms of a third party immunoprotective device,” said Robert Millman, CEO of Semma Therapeutics. “We’re excited for the collaboration and look forward to the results.” This exemplary cooperation was recognized as “Best innovative trial design leading to a quicker and better therapeutic outcome” at the MedStartup - Galien Award event on 27 October 2016 in New York. For Defymed, the collaboration follows just six months after concluding a financial agreement for half a million dollars with the JRDF, a global foundation that funds research into treatment for type-1 diabetes. Defymed also has the support and accompaniment of Business France for its development in the United States. The Strasbourg biotech company is keen to become established in this important market in the very near future. About Defymed Defymed, a spin-off of the European centre for the study of diabetes CeeD (Centre Européen d’Étude du Diabète), is a biotechnology company set up in March 2011; it specialises in the design and development of innovative bio-artificial medical devices. Defymed’s initial focus is on developing an application for treating type 1 diabetes. The first product it has designed is MAILPAN©, an implantable bio-artificial pancreas intended to re-establish the normal production of insulin in type 1 diabetics. The MAILPAN© prototype was produced with financial support from the European Commission. The company owns exclusive technology that enables it to produce medical devices for use in other therapeutic applications. Defymed’s strength lies in its network of French and international partners. For more information, please visit www.defymed.com. About Semma Therapeutics Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring new therapeutic options to the clinic and improve the lives of patients with diabetes. The company is headquartered in Cambridge, MA. For more information, visit www.semma-tx.com. COMMUNIQUE DE PRESSE DEFYMED 8 Avenue Dante 67000 Strasbourg - France Tel. +33 (0)3 90 41 04 46 www. defymed .com Further information and visuals available on request from our press service: OXYGEN | Press contacts 2 Rue d’Ingwiller - 67000 Strasbourg [France] Elise Cordier +33 (0)3 67 22 03 25 - elisec@oxygen-rp.com Jérémie Lotz +33 (0)6 11 25 48 05 - jlotz@oxygen-rp.com  

Laser Stripping Becomes a Reference in the Field of Cabling

PRESS - 06-déc.-2016 23:57:21

  Laser Stripping Becomes a Reference in the Field of Cabling Over the last two decades the aerospace industrial landscape has seen a tremendous surge in laser processing solutions (cutting, welding, marking, etc.). Electrical harness manufacturing is a booming sector driven by the strong growth of aircraft production and the race for autonomous cars (multiplication of sensors and multimedia systems, complexity of the harnesses). The use of high-precision laser solutions for marking or stripping of a lighter, technical and sensitive electric cable is constantly increasing. In recent years, cable laser stripping machines have followed a trend of sophistication, increased power, size and capacity to try to penetrate new markets in the industry. Laselec has chosen to work against the flow by relying on innovation, miniaturization, ergonomics and ease of use. Laselec has developed Sylade, a patented technology for contactless cable stripping based on laser diodes. Sylade technology is integrated in the field of aerospace cabling and offers a level of precision, quality and consistency far superior than that of traditional tools. Laser stripping is establishing itself as the best solution for the stripping of shielded, twisted and multi-filament cables and meets the new requirements of the aerospace standards ASD EN2812, SAE AIR6894 updated and published in recent months. The Sylade products - available as a stand-alone or integrated in an automated harness manufacturing solution- perfectly meets the need for stripping aluminum cables used in the transport sectors as well. Their use guarantess not to damage the ultra-sensitive strands of these new families of technical cables. Public Relations Contact : Marie-Line LAVAL, Global Sales Director info@laselec.com +33 (0)5 82 950 550 www.laselec.com        

A Look Back: MEDSTARTUP 2016

Elsa RIVE - 22-nov.-2016 23:01:16

  A Look Back: MEDSTARTUP 2016 Business France & The Galien Foundation were pleased with the Medstartup Partnering Day where: NETWORK with +200 Leaders in the EHealth/Pharma/Medtech industrie SOURCE INNOVATION Meet with +50 innovative French Health Tech companies            EXPAND Identify strategic partners to access to the European market     For the second consecutive year, Medstartup was honored to involve inspiring leaders in the industry and fantastic jury composed by Bernard Poussot, Director, Roche Holding, Former Chairman & CEO, Wyeth - Roch DOLIVEUX - Honorary CEO, UCB -Mikael DOLSTEN - Global R&D President, Pfizer -Jean-Pierre GARNIER – Former CEO, GSK -Franz HUMER - Former CEO, Roche -François MAISONROUGE - Senior Managing Director, EvercorePartners -Paul STOFFELS - Chief Scientific Officer, Johnson and Johnson -Elias ZERHOUNI - Global R&D President, Sanofi Key Figures & Facts: +20 New EU-US collaborations per year +65% of C-Levels +550 BtoB Meetings +250  Leaders Every year, MedStartUp Program organized by the Galien Foundation & Business France encourages and rewards transatlantic partnerships in the Healthcare industries. The MedstartUp brought together:   50 highly innovative French companies in the healthcare industry and 200 American leaders in the Pharma/MedTech /Digital Health industries.  Watch the videos of two of the many of the innovative French companies that were at this year’s MedStartUp: Metabolys: Metabolys is developing breakthrough treatments for metabolic diseases with a particular focus on Type 2 Diabetes and NonAlcoholic SteatoHepatitis (NASH)   Protec’Som: Laboratoire Protec’Som is a French medical devices designer whose core jobs are Respiratory Drug Delivery and Protections against allergens. LLTech: In the clinical setting, LLTech seeks to improve clinical practice, patient comfort and hospital economics by accelerating and improving the diagnostic process as well as avoiding repeat procedures.         For further information, visit our website medstartup.galienfoundation.org/wp                

Innovative French Delegation Back at RSNA 2016

Laura LANDRY - 09-nov.-2016 23:41:48

  With less than three weeks away from the RSNA annual meeting, the ten French companies that are part of our delegation this year are gearing up to exhibit among 55,00 attendees among 140 countries across the globe in McCormick Place in Chicago.  The French delegation will represent France with their cutting edge technologies in the radiology industry. Read more about their technologies below and how these companies can impact the radiology and medical industry. Don’t forget to stop by their respective booths to meet the delegation! DMS Imaging DMS Imaging is a high-tech French company specialized in medical imaging diagnostics.  With over 30 years of experience, the brands that make up DMS Imaging: Apelem , DMS , AXS Medical and Medilink offer a complete range of innovative solutions in radiology, bone densitometry, stereo-radiography and posturology, all of which are adapted to the demands of the global marketplace.  Our network of distributors in 140 countries across the globe contribute to the international dimension of our products’ quality.   NGI With over 1,200 private and public, mono and multi-site customers, NGI is the French leader in support dedicated to radiology groups and imaging centers. As a developer/publisher, distributor and integrator, NGI is the only group in France that offers a fully-integrated one stop solution: - Radiography System - Women’s imaging - Ultrasound - Dental Imaging - RIS (Radiologic Information System) - PACS (Picture Archiving & Communication System) - Diagnostic - Transmission (patient booklet printout, web distribution, etc.) Fiber Metrix Fibermetrix propose innovative solutions for real-time dose monitoring of ionizing radiations within the medical field. Based on fundamental research, its first patented sensor provides automatic feedback of patient dose (including two major dose indicators : CTDI and DLP) to increase radiation awareness during a computed tomography (CT) exam. Already used for research purposes, this optical fiber sensor, full integrated in the CT patient couch, will be available during 2017 Nicesoft Nicesoft has been developing innovative and creative solutions for Medical Imaging professionals since 1998, combining cloud computing technology and a high specialization in Nuclear Medicine. The complementary and fully-integrated range of products is composed entirely of zero footprint web-based solutions: - Venus RIS - Venus Explorer - Venus Archive - Venus Share Oscadi Oscadi is proud to present you his connected ultrasound: Oscult - The ultimate diagnosis tool. OSCULT is a handheld ultrasound imaging device interfaced with the Apple iPad. Its smart design, intuitive interface and exclusive new features will definitely change health professionals everyday diagnosis. With OSCULT, you are always connected and you can at any time collaborate with a specialist that will help your diagnosis. The network capabilities of OSCULT also allow you to securely save your images and patient data on the cloud. Schiller Medical SCHILLER Medical is a Swiss, Family owned company build in 1974. Designing, manufacturing and distributing high-end medical electronics. Worldwide expert in cardiopulmonary diagnostic systems, rescue devices, it is also a leading company in MRI compatible vital sign monitoring since 1980. Sonoscanner Sonoscanner presents at RSNA 2016 its new ultrasound scanner : U-Lite™. U-Lite (www.uliteit.com) is the new generation of Ultrasound scanner. High-end image features on hand-held device, now FDA Approved. Its subsidiary, Sonoscanner US LLC is in charge of U-Lite™ commercial development in the US MammoRisk MammoRisk  is an innovative software tool for assessing breast cancer risk. It provides clinical decision support to establish personalized screening plans. MammoRisk was developed in collaboration with Gustave Roussy, the biggest comprehensive Cancer Center in Europe, and the Breast Cancer Screening Consortium (BCSC) in US. MammoRisk is a product of Statlife, an innovative company specializing in statistics and data miningapplied to Predictive and Preventive Personalized Participative (4P Medicine). Medsquare Medsquare provides innovative solutions for the medical imaging environment. Our solutions (burning, printing, archiving, secured web image distribution) are currently being used in most of the university hospitals and private clinics in France and around the world. Medsquare is also a leading player in the DACS (Dose Archiving & Communication System) market. Our Radiation Dose Monitor – RDM – is a multi-modality software solution that helps healthcare organizations optimize radiation dose and clinical practices. In 2016, all DACS public tenders were awarded to Medsquare. Toutenkamion Toutenkamion is a specialized coachbuilder supplying a wide range of customers active in a variety of fields. It specializes in creation of units for medical support, mobile medical units on light or heavy trucks, trailers or semi-trailers for blood donation, digital mammography, audiology, ophthalmology, surgery, dentistry, polyclinics, dispensaries… Each mobile unit, with or without extension, is designed specifically. Design, manufacturing and interior layout are entirely and exclusively carried out in toutenkamion workshops. The company has delivered highly complex units to over thirty countries, mostly in Europe, Asia, Africa and Far East.                      

Smoove becomes the first operator to provide an African city with bike-sharing program

PRESS RELEASE - 07-nov.-2016 16:43:48

  Smoove to provide Marrakesh with self-service bike-sharing scheme   Smoove becomes the first operator to provide an African city with bike-sharing program     Marrakech will be the first city in Africa to implement a  bike-sharing scheme Launch of 300 self-service bikes for COP22 in Marrakesh (7 th -18 th November) Having already implemented self-service bike schemes in Moscow, Vancouver, Helsinki and Slough, Smoove aims to increase its international presence further and hopes to offer bike-sharing solutions in other parts of the UK. They are currently working on a ‘call for tender’ for a bike-sharing scheme in Brighton    Smoove won the tender organised by the United Nations Industrial Development Organisation (UNIDO) to roll out a fleet of self-service bikes for COP22, the UN Climate Change Conference, which is taking place from 7 th -18 th November 2016 in Marrakesh. Medina Bike , set up in partnership with local organisation ‘Estates Vision’, will be the equivalent of Boris Bikes in Marrakesh and the first city in Africa to benefit from such a scheme. The fleet, of 300 bikes and around 10 stations, will be installed in the most emblematic locations of the city, such as Koutoubia or Majorelle Garden. The service will be inaugurated for COP22 and will be maintained over time with a renewable contract for an initial term of five years. Similar to Moscow, Helsinki and Vancouver, the low-cost Medina Bike model will include the contribution of a sponsor, which has not yet been selected. Medina Bike is one of the ways to meet King Mohammed VI’s and the Moroccan Government’s goals on practical initiatives for sustainable development for COP 22. The project, which is an initiative of the Moroccan Ministry of the Environment, organised by UNIDO and funded by the Global Environmental Facility (GEF), confirms Morocco’s commitment to the fight against the negative impact of climate change. The twenty-second session of the Conference of Parties (COP22) will bring together 197 states and, according to the organisers, will be the COP of action. “ Bikes were once one of the main means of transport in Marrakesh, but have gradually lost ground. We hope that Medina Bike will bring about a cycling revolution. We are very proud to have won this prestigious tender. It marks our commitment to promote self-service bike-sharing schemes for more pleasant, greener cities. Thank you Marrakesh! The so-called ‘red city’ has made Smoove the first  bike-share provider in Africa! " explains Laurent Mercat, CEO of Smoove. Smoove is one of the leading bike-share providers in the world thanks to its innovative solutions: robust, smart bikes with embedded communication technology (‘Smoove Box’) and light, free-standing stations powered by solar energy with no major or civil works required for installation. Smoove’s technological know-how has enabled it to offer an ‘overflow’ feature so that a bike can be returned even if the station is full. Thanks to these competitive advantages, Smoove has experienced accelerated international growth this year. “ This project in Marrakesh is the perfect way to end a very busy and successful year for Smoove. In spring, we installed a fleet of 1,500 bikes in Helsinki, the capital of Finland, followed by fleets in Vancouver, Canada, in July and in Shymkent and Almaty in Kazakhstan later in the summer. We also carried out the second phase of roll-out in Moscow where there are now more than 3,450 bikes !" comments Hélène Papa, Marketing and Communication Manager. Well positioned to renew fleets in major cities “ Our facilities in major cities across the world theoretically make us a strong contender for the renewal of all the first generation contracts, such as Vélib in Paris ," adds Laurent Mercat, CEO of Smoove. Competing for the tender alongside Indigo, Moventia and their new shareholder Mobivia, all experts in the field, Smoove has been selected in the competitive dialogue procedure to renew the “Vélib” fleet in Paris. Their bid is in progress and the operator will be chosen in April 2017. Smoove generated €8 million (around £7.2million) in revenue in 2016. This revenue, like the number of employees, has doubled every two years since the company was formed. Their 2017 objectives are even more ambitious. Fifteen per cent of the revenue is reinvested in R&D to meet the demands of the city of the future (E Bike, bluetooth connection, mobile application, IoT, etc.) to better ‘facilitate sustainable mobility’. For more information about MEDINA BIKE / ESTATES VISION , please visit: www.medinabike.ma For further information on SMOOVE, please contact :   Laurent Mercat , CEO of Smoove   l.mercat@smoove.fr   / +33 4 67 67 89 00   Hélène Papa , Marketing and Communication Manager   h.papa@smoove.fr / +33 6 75 64 96 68 / 04 11 57 01 19   @Smoove_Off     W    www.smoove.fr /newsroom   For further information on this press release, please contact: Catherine Ryall, Business France UK Press Office Email: catherine.ryall@businessfrance.fr Web: www.youbuyfrance.com/uk/      

LASELEC CELEBRATES 15 YEAR ANNIVERSARY WITH ELECTRICAL HARNESS AUTOMATION AT NBAA 2016

PRESS RELEASE - 17-oct.-2016 18:06:52

  Press release October 2016   LASELEC CELEBRATES 15 YEAR ANNIVERSARY WITH ELECTRICAL HARNESS AUTOMATION AT NBAA 2016 Founded in 2001, LASELEC designs and manufactures cutting-edge electrical wire processing equipment: UV laser wire markers, laser wire strippers, interactive harness assembly boards, harness braiding machines. This wide range of products demonstrates the company’s willingness for continuous innovation and leadership in the latest trends in aircraft electrical harness manufacturing – And that latest trend is AUTOMATION ! LASELEC will present its automatic solutions in a special presentation at the NBAA 2016 show:   The RAPIDSHARE Automated Wire Processing Line Prior to RapidShare being launched, the first step in the manufacturing process of an aerospace electrical harness started with the marking and cutting of wires. Next the operator had to manually group the batch of wires. Then the operator would label and sort those batches for production processing before sending them to the shop floor for assembly on a form board. Laselec has initiated the new trend in the harness manufacturing with GE Aviation being the first customer to experience an unprecedented level of automation. RapidShare is a solution designed to automate wire processing production.   The RapidShare robot arm, attached to the ULYS Modena laser wire marker, is able to perform automatic tasks such as:   labelling, stripping, crimping, bundling and kitting processes.   The operator is now free to handle multiple tasks/machines instead of operating a single marking machine for an entire shift. RapidShare’s compatibility with the ULYS Modena line of laser wire markers has allowed companies, such as Airbus Group which owns several Laselec’s markers, to   upgrade to the automated production system that has increased their competitiveness. Also on display during NBAA 2016, is the ALL NEW Sylade 7 laser wire stripper . The Laselec patented laser cutting technology is a safe solution for jacket stripping of MIL-SPEC cables. This all new version features a trigger sensor, auto-select strip lengths and a faster cutting process. With SYLADE, jacket stripping becomes SAFE, QUICK and FUN! The EasyWiring interactive harness form board will be on display at NBAA 2016 as well.   This digital wiring harness board replaces the traditional wooden boards. The embedded software provides a step by step guided assembly processes to increase manufacturing productivity and reduce cabling errors. In addition to Rapidshare, LASELEC has also launched its new over-braiding machine. The BRAIDO series provides complete automation for the production of overbraiding. The software, developed by LASELEC, offers many functions allowing a significant increase in productivity. BRAIDO customers especially appreciate the simplicity of the braiding operation as well as the machine’s impressive speed and low noise reduction. By networking different BRAIDO machines the operator can begin the work on one machine and transfer the job to another machine and still maintain the continuity of the traceability data. LINK BELOW FOR COMPLETE PRESS RELEASE. For further information: Frederick Viaut, Sales Manager frederick.viaut@laselec.com Richard Hinegardner, Sales Representative Richard.hinegardner@laselec.com Phone: 817-460-7830 www.laselec.com          

About us
Henri Baissas: "Welcome to Business France North America! We assist French companies who want to export in North America, and North American companies who want to invest in France. Our team has both the knowledge and the experience to facilitate BtoB trade relations between the three countries. With offices and branches in New York, Boston, Toronto, Montréal, Atlanta, Detroit, Chicago, Houston, Vancouver, and San Francisco, Business France North America is present from coast to coast. Close to 100 Business France experts focus on the following sectors: - Agrotech (wine, spirits, beer, beverages, food, and equipments for the agricultural and food industry) - Industry & clean tech (public works & transportation, energy & clean techs, industry) - Art de vivre & healthcare (biotechnologies, cosmetics, healthcare, fashion, luxury, culture, sport, home decor and tourism) - Tech & services (new technologies, retail and services, innovation

READ MORE

    
    You Buy France 

    

    Rail industry 

   

    Vivapolis  

   

    Healthindustry

   

    Axema

          
   
Facebook
Press area & Media Gallery
List of last comments